FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
The Food and Drug Administration (FDA) today issued a public health advisory to inform patients and health care // providers about the suspended marketing of Tysabri (nataluzimab) while the agency and the manufacturer evaluate two serious adverse events reported with its use. Tysabri, which received accelerated approval from FDA in November 2004, is an innovative treatment that repre...Doctors Said – ‘Stop Pressurising NHS Advisory Bod’
The NICE (National Institute for Health and Clinical Excellence) carried out study regarding whether if new drugs and technologies are cost effective or not//....Merck's Pain Reliever Arcoxia Rejected by US Federal Advisory Panel
An advisory panel of the United States Food and Drug Administration (FDA) has rejected pharmaceutical giant Merck's bid to market Arcoxia,// a new osteoarthritis medication following concerns that it may carry cardiovascular risks. Osteoarthritis is a joint disease that mostly affects cartilage. Cartilage is the slippery tissue that covers the ends of bones in a joint. Whil...FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
Anti-depressants could indeed lift one out of depression. But its potential to drive teenagers to suicide has already been recognized//. Now the U.S. Food and Drug Administration (FDA) has proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased risks of suicidal thinking and behavior,...FDA Advisory Against Anti-depressants to Be Expanded to Cover Young Adults too
Anti-depressants could indeed lift one out of depression. But its potential to drive teenagers to suicide has already been recognized . Now the U.S. Food and Drug Administration (FDA) has proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased risks of suicidal thinking and behavior,...LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation
LifeCycle Pharma has established a Scientific Advisory Board for its transplantation programs. In addition, LifeCycle Pharma announces the expansion of its United States (U.S.) clinical development department with the addition of Drs. Rob Gordon and Larry Chodoff LifeCycle Pharma A/S OMX:LCP) today announced the formation of an international Scientific Advisory Board (SAB) of experts in...